Moxifloxacin Export Market Intelligence: India's 336 Suppliers Shipping to 137 Countries — TransData Nexus 2026

Q: Who are the top moxifloxacin exporters from India?

The top moxifloxacin exporters from India are: 1. MACLEODS PHARMACEUTICALS LTD — $14.7M (44.9% market share); 2. MSN LABORATORIES PRIVATE LIMITED — $2.3M (7.0% market share); 3. EUGIA PHARMA SPECIALITIES LIMITED — $2.3M (7.0% market share); 4. MICRO LABS LIMITED — $2.3M (7.0% market share); 5. AJANTA PHARMA LIMITED — $1.4M (4.2% market share). Together they account for 70.1% of India's total moxifloxacin export value.

Q: What is the total export value of moxifloxacin from India?

The total export value of moxifloxacin from India is $32.8M USD, recorded across 2,413 shipment transactions from 336 active exporters to 137 destination countries. The average shipment value is $13.6K.

Q: Which countries import moxifloxacin from India?

India exports moxifloxacin to 137 countries worldwide. The top importing countries are: NIGERIA (44.8% share, $14.7M), UNITED STATES (17.5% share, $5.8M), NETHERLANDS (5.1% share, $1.7M), THAILAND (3.2% share, $1.0M), FRANCE (2.2% share, $737.5K). These five markets account for 72.8% of total export value.

Q: What is the HS code for moxifloxacin exports from India?

The primary HS code for moxifloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of moxifloxacin exports from India?

The average unit price for moxifloxacin exports from India is $7.12 USD per unit, with prices ranging from $0.00 to $383.19 depending on formulation, packaging, and order volume. The total market is valued at $32.8M across 2,413 shipments.

Q: Which ports handle moxifloxacin exports from India?

The primary ports for moxifloxacin exports from India are SAHAR AIR (12.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.3% of shipments), DELHI AIR (5.5% of shipments), NHAVA SHEVA SEA (INNSA1) (5.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of moxifloxacin?

India is one of the world's leading exporters of moxifloxacin due to its large base of 336 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports moxifloxacin to 137 countries, demonstrating 70% global market coverage.

Q: What certifications do Indian moxifloxacin exporters need?

Indian moxifloxacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import moxifloxacin from India?

There are 731 registered buyers importing moxifloxacin from India, spread across 137 countries. The repeat buyer rate is 51.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top moxifloxacin supplier from India?

MACLEODS PHARMACEUTICALS LTD is the leading moxifloxacin exporter from India with a market share of 44.9% and total export value of $14.7M across 27 shipments. The top 5 suppliers together control 70.1% of total export value.

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Moxifloxacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Moxifloxacin to the World

Between 2022 and 2026, India exported $32.8M worth of moxifloxacin across 2,413 verified shipments to 137 countries — covering 70% of world markets in the Advanced Antibiotics segment. The largest destination is NIGERIA (44.8%). MACLEODS PHARMACEUTICALS LTD leads with a 44.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Moxifloxacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Moxifloxacin export data snapshot — $32.8M · 336 exporters · 137 countriesTransData Nexus · Indian Customs Data

Top Moxifloxacin Exporters from India

336 active exporters · Ranked by export value

View all 336 →

Top Moxifloxacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MACLEODS PHARMACEUTICALS LTD	$14.7M	27	14	44.9%
2	MSN LABORATORIES PRIVATE LIMITED

Top Countries Importing Moxifloxacin from India

137 destination markets · Ranked by import value

All 137 countries →

Top Countries Importing Moxifloxacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NIGERIA	$14.7M	44.8%
2	UNITED STATES	$5.8M	17.5%
3	NETHERLANDS	$1.7M	5.1%
4	THAILAND	$1.0M	3.2%
5	FRANCE	$737.5K	2.2%
6	IRAQ	$702.2K	2.1%
7	VENEZUELA	$520.6K	1.6%
8	MEXICO	$515.9K	1.6%
9	UZBEKISTAN	$495.6K	1.5%
10	CAMBODIA	$483.6K	1.5%

NIGERIA is India's largest moxifloxacin export destination, absorbing 44.8% of total exports worth $14.7M. The top 5 importing countries — NIGERIA, UNITED STATES, NETHERLANDS, THAILAND, FRANCE — together account for 72.8% of India's total moxifloxacin export value. The remaining 132 destination countries collectively receive the other 27.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Moxifloxacin to India?

16 origin countries · Total import value: $191.1B

India imports moxifloxacin from 16 countries with a combined import value of $191.1B. The largest supplier is UNITED STATES ($160.3B, 34 shipments), followed by BRAZIL and SWITZERLAND. All values are from Indian Customs (DGFT) import records.

Countries Supplying Moxifloxacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$160.3B	34	83.9%
2	BRAZIL	$30.7B	8	16.1%
3	SWITZERLAND	$1.5M	6	0.0%
4	GERMANY	$90.0K	4	0.0%
5	AUSTRALIA	$6.2K	2	0.0%
6	IRELAND	$5.0K	2	0.0%
7	HUNGARY	$3.7K	1	0.0%
8	NETHERLANDS	$2.1K	2	0.0%
9	LATVIA	$2.0K	1	0.0%
10	CANADA	$1.8K	1	0.0%

Showing top 10 of 16 origin countries

UNITED STATES is the largest supplier of moxifloxacin to India, accounting for 83.9% of total import value. The top 5 origin countries — UNITED STATES, BRAZIL, SWITZERLAND, GERMANY, AUSTRALIA — together supply 100.0% of India's moxifloxacin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Moxifloxacin — Export Intelligence Video

Visual overview of India's moxifloxacin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's moxifloxacin pharmaceutical import and export market — $32.8M in total trade, 336 verified manufacturers, and 137 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Moxifloxacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, moxifloxacin is approved for various indications, including the treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and community-acquired pneumonia. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for moxifloxacin, indicating a competitive generic market. The regulatory pathway for moxifloxacin involves demonstrating bioequivalence to the reference listed drug, ensuring safety and efficacy standards are met. Given that 17.5% of India's moxifloxacin exports are directed to the U.S., compliance with FDA regulations is paramount for Indian exporters.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) has authorized moxifloxacin for similar indications as in the U.S. However, in July 2008, the EMA recommended restricting the use of oral moxifloxacin-containing medicines to cases where other antibiotics cannot be used or have failed, due to concerns over liver safety. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA guidelines, emphasizing the importance of adhering to these restrictions. Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) requirements to ensure product quality and safety.

3WHO Essential Medicines & Global Standards

Moxifloxacin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating bacterial infections. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications globally.

4India Regulatory Classification

In India, moxifloxacin is classified under Schedule H1 of the Drugs and Cosmetics Rules, indicating it is a prescription-only medication with specific labeling and prescription requirements to prevent misuse. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for moxifloxacin, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for moxifloxacin have expired, leading to increased generic competition. This has resulted in a diversified market with multiple manufacturers producing moxifloxacin, contributing to its widespread availability and competitive pricing.

6Recent Industry Developments

In February 2024, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updates to the product information for moxifloxacin-containing medicines, emphasizing the risk of QT interval prolongation and associated cardiac events. (ema.europa.eu) In December 2025, the EMA approved an extension of the indication for Dovprela (pretomanid) to include combination therapy with moxifloxacin for certain types of drug-resistant tuberculosis, highlighting moxifloxacin's role in complex treatment regimens. (ema.europa.eu)

These developments underscore the dynamic regulatory landscape surrounding moxifloxacin, necessitating continuous monitoring and compliance by exporters to maintain market access and ensure patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Moxifloxacin

Retail & reference prices across 9 markets vs. India FOB export price of $7.12/unit

Global Price Benchmark for Moxifloxacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.04–$2.63	USD	According to the FDA, Moxifloxacin is approved for various bacterial infections.
United Kingdom	Data not available	GBP	Moxifloxacin is listed in the British National Formulary (BNF) for the treatment of bacterial infections.
Germany	Data not available	EUR	Moxifloxacin is approved by the European Medicines Agency (EMA) for use in bacterial infections.
Australia	Data not available

Supply Chain Risk Assessment — Moxifloxacin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 80% of India's API requirements are fulfilled by Chinese manufacturers, creating a significant dependency. This reliance was starkly highlighted during the COVID-19 pandemic, which disrupted global supply chains and led to substantial shortages in essential drugs.

In response, the Indian government introduced the Production Linked Incentive (PLI) Scheme to bolster domestic API manufacturing and reduce import dependence. This initiative aims to rebuild India's API ecosystem by enhancing local capacity and technological capabilities. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

The concentration of Moxifloxacin exports among the top five suppliers, accounting for 70.1% of the total export value, poses a significant single-source risk. MACLEODS PHARMACEUTICALS LTD alone contributes 44.9% of exports. Such concentration can lead to supply disruptions if any of these key suppliers face operational challenges.

The PLI Scheme is a strategic move to mitigate this risk by promoting diversification and self-reliance in API production. By incentivizing domestic manufacturing, the scheme aims to reduce dependency on a limited number of suppliers and enhance the resilience of the pharmaceutical supply chain. (pharmanow.live)

Access Complete Moxifloxacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,413 transactions across 137 markets.

Request Demo View Pricing

Frequently Asked Questions — Moxifloxacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top moxifloxacin exporters from India?

The leading moxifloxacin exporters from India are MACLEODS PHARMACEUTICALS LTD, MSN LABORATORIES PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, and 12 others. MACLEODS PHARMACEUTICALS LTD leads with 44.9% market share ($14.7M). The top 5 suppliers together control 70.1% of total export value.

What is the total export value of moxifloxacin from India?

The total export value of moxifloxacin from India is $32.8M, recorded across 2,413 shipments from 336 active exporters to 137 countries. The average shipment value is $13.6K.

Which countries import moxifloxacin from India?

India exports moxifloxacin to 137 countries. The top importing countries are NIGERIA (44.8%), UNITED STATES (17.5%), NETHERLANDS (5.1%), THAILAND (3.2%), FRANCE (2.2%), which together account for 72.8% of total export value.

What is the HS code for moxifloxacin exports from India?

The primary HS code for moxifloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Moxifloxacin

Moxifloxacin

Top Moxifloxacin Exporters from India

Top Countries Importing Moxifloxacin from India

Who Supplies Moxifloxacin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Moxifloxacin — Export Intelligence Video

Regulatory Landscape — Moxifloxacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Moxifloxacin

Supply Chain Risk Assessment — Moxifloxacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Moxifloxacin Trade Intelligence

Frequently Asked Questions — Moxifloxacin Exports from India

Who are the top moxifloxacin exporters from India?

What is the total export value of moxifloxacin from India?

Which countries import moxifloxacin from India?

What is the HS code for moxifloxacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of moxifloxacin exports from India?

Which ports handle moxifloxacin exports from India?

Why is India a leading exporter of moxifloxacin?

What certifications do Indian moxifloxacin exporters need?

How many buyers import moxifloxacin from India?

What is the market share of the top moxifloxacin exporter from India?

Analysis Methodology